William Blair announced the continued expansion of the firm’s robust life sciences practice with the additions of Neha Motwani and Rizwan Velji as managing directors. Based in the firm’s New York office, Motwani and Velji bring deep knowledge and...
view press release
September 29, 2021, 08:00 AM
|
EisnerAmper announced the following leadership appointments within its Technology and Life Sciences Services Group, effective January 1, 2021. Marc Fogarty: National Biotech Sector Leader - Marc is an audit partner with more than 20 years of...
view press release
January 29, 2021, 08:00 AM
|
Tree Line Capital Partners, LLC, a direct lender focused on the lower middle market, provided a first lien credit facility, including a term loan, revolver and delayed draw facility, and equity co-investment to support Huron Capital Partners’...
view press release
January 22, 2019, 08:00 AM
|
Ardelyx, Inc., a developer of medical therapies, announced it has entered into a $50 million senior secured term loan facility with Solar Capital Ltd. and the Life Sciences Group at Bridge Bank, a division of Western Alliance Bank. The loan was...
view press release
May 22, 2018, 08:00 AM
|
GPB Capital Holdings, LLC (GPB Capital) announced that it has made a debt investment in Emmaus Life Sciences, Inc. (Emmaus). Proceeds from the investment will help Emmaus commercially launch Endari™ (L-glutmamine oral powder), its prescription...
view press release
January 19, 2018, 08:06 AM
|
Ironwood Capital Connecticut, a unit of Ironwood Capital, announced an investment in IsoPlexis, a venture-capital funded life sciences company developing a diagnostic platform to measure cellular immune response in patients. "IsoPlexis has...
view press release
November 29, 2016, 07:04 AM
|
GE Capital’s Healthcare Financial Services business ended 2013 as one of the most active capital providers in the U.S. healthcare market, deploying approximately $9 billion in new commitments to customers in over 200 transactions. For the fourth...
view press release
January 14, 2014, 07:29 AM
|
Square 1 Bank provided a $2.25M debt facility to new client Carolus Therapeutics, a biopharmaceutical company. The financing will support future growth.
Founded in 2008, Carolus Therapeutics is committed to the development of innovative new drugs...
view press release
March 07, 2013, 08:04 AM
|